CytoImmune Therapeutics Employee Directory

Biotechnology ResearchCalifornia, United States51-200 Employees

CytoImmune Therapeutics, LLC develops novel, coordinated immunotherapy solutions for patients.

Our CoalesceNT™ platform harnesses the power of bispecific antibody (biAb) and chimeric antigen receptor (CAR) technology to coordinate an immune response with both natural killer (NK) and T cells. This combination of NK- and T-cell therapy expedites time-to-treatment and delivers a dynamic immune response that reflects natural immunity.

Find CytoImmune Therapeutics employees' phone numbers or email addresses

CytoImmune Therapeutics Global Highlights

North America
63

United States Of America
63

CytoImmune Therapeutics's Leadership

J. E. V.
Chief Executive Officer
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. V.
Chief Medical Officer
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
O. B.
Vice President Regulatory Affairs
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. A.
Head Of Supply Chain Operations
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. A.
Head Of Supply Chain Operations
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. T.
Head Of Analytical Operations
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
W. R.
President
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. C.
Co-Founder
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Contact profiles from CytoImmune Therapeutics

Name

Title

Contact Info

Location

Last Update

W. R.
President
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
United States
Oct 30, 2024
J. E. V.
Chief Executive Officer
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Puerto RicoSan Juan
Oct 17, 2024
M. C.
Co-Founder
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Oct 22, 2024
R. V.
Chief Medical Officer
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Oct 22, 2024
I. B.
Vp Preclinical Affairs
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
United States
Oct 21, 2024
Y. C.
Manufacturing & Operations Lead/ Head Of Manufacturing
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Puerto Rico
Oct 08, 2024
O. B.
Vice President Regulatory Affairs
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Oct 22, 2024
J. A.
Head Of Supply Chain Operations
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
United StatesFlorida
Oct 22, 2024
J. A.
Head Of Supply Chain Operations
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Puerto Rico
Oct 22, 2024
M. T.
Head Of Analytical Operations
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
United StatesMassachusetts
Oct 18, 2024

Frequently Asked Questions

What is CytoImmune Therapeutics known for?

CytoImmune Therapeutics was founded in 2019 operates in the Biotechnology Research industry. The company's main headquarters is located in 1218 S 5th Ave Monrovia, California 91016 US. Explore CytoImmune Therapeutics's company overview page for more information.

What is CytoImmune Therapeutics's most common email format?

CytoImmune Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more CytoImmune Therapeutics email formats with LeadIQ.

How many employees does CytoImmune Therapeutics have currently?

CytoImmune Therapeutics has approximately 51 employees as of October 2024. These team members are located across 1 continents, including North America.

Who are CytoImmune Therapeutics's key employees and leadership?

As of October 2024, CytoImmune Therapeutics's key employees include:

Chief Executive Officer: J. E. V.
Chief Medical Officer: R. V.
Vice President Regulatory Affairs: O. B.
Head Of Supply Chain Operations: J. A.
Head Of Supply Chain Operations: J. A.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking